ANDA 84916, held by Fresenius Kabi USA. Dexamethasone Sodium Phosphate.
As of Nov 21, 2026, ANDA 84916 (Dexamethasone Sodium Phosphate), held by Fresenius Kabi USA, was first approved by FDA on Sep 6, 1977, with 20 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE: Intravenous or Intramuscular Injection When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, those products labeled for intravenous or intramuscular use are indicated as follows:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 6, 1977 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dexamethasone Sodium PhosphateEQ 4MG PHOSPHATE/ML · injectable;injection | Dexamethasone Sodium Phosphate | RxReference drug |
| Jun 5, 2024 | Supplement 75Labeling · Standard review | Approved | None posted |
| Jul 28, 2020 | Supplement 69Labeling · Standard review | Approved | None posted |
| Jul 28, 2020 | Supplement 65Labeling · Standard review | Approved | None posted |
| Jul 3, 2014 | Supplement 66Labeling · Standard review | Approved | |
| Dec 5, 2002 | Supplement 57Manufacturing | Approved | None posted |
| Jun 13, 2001 | Supplement 56Manufacturing | Approved | None posted |
| Jul 20, 1995 | Supplement 54Labeling | Approved | None posted |
| Jan 11, 1994 | Supplement 53Labeling | Approved | None posted |
| Sep 13, 1991 | Supplement 51Manufacturing | Approved | None posted |
| Jun 13, 1991 | Supplement 52Labeling | Approved | None posted |
| Feb 6, 1991 | Supplement 50Labeling | Approved | None posted |
| Jul 12, 1989 | Supplement 48Labeling | Approved | None posted |
| Nov 2, 1988 | Supplement 47Labeling | Approved | None posted |
| Jun 13, 1986 | Supplement 43Manufacturing | Approved | None posted |
| Jan 3, 1985 | Supplement 39Manufacturing | Approved | None posted |
| Jan 3, 1985 | Supplement 38Manufacturing | Approved | None posted |
| Dec 6, 1984 | Supplement 40Manufacturing | Approved | None posted |
| Jan 17, 1984 | Supplement 35Manufacturing | Approved | None posted |
| Dec 6, 1983 | Supplement 34Manufacturing | Approved | None posted |
| Apr 19, 1982 | Supplement 30Manufacturing | Approved | None posted |
| Sep 6, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters